Regulation And Legal
MPS Pharmaa Reports Nil Investor Complaints Q4
MPS Pharmaa Limited submitted a mandatory quarterly investor complaint statement to BSE and ASE.
The filing disclosed zero investor complaints pending, received, or resolved for the quarter ended Marc
